Thorsten Oliver Goetze und Institute Of Clinical Person-Info 

( Ich bin Thorsten Oliver Goetze)
(1 - 6 von 7
)

Durvalumab Plus Chemo Improves Survival for Small Cell Lung ...www.cancer.gov › news-events › cancer-currents-blog

www.cancer.gov
· ... SCLC as a new standard of care,” wrote Thorsten Oliver Goetze, M.D., of the Institute of Clinical Cancer Research in Frankfurt, Germany, ...
+1